To investigate trafficking between adipose tissue and atherosclerotic plaques, we incorporated into the protocol eWAT donors with the congenic pan-leukocyte marker CD45.1 and, as recipients, CD45.2+Ldlr–/– mice with atherosclerosis (Figure 4A). Here, LDLR is linked to atherosclerosis.